Spark gene therapy for blindness could come at steep cost – BioPharma Dive
|
Spark gene therapy for blindness could come at steep cost
BioPharma Dive Early next year, Spark Therapeutics Inc.’s gene therapy Luxturna could become the first such treatment for an inherited condition to win approval in the U.S., bringing with it new hope for patients with a rare form of childhood blindness. At the same … |
FierceBiotech |
Improving cancer immunotherapy by harnessing new technology
FierceBiotech “We think we have developed a straightforward way to modify the really important immunotherapy drugs that work remarkably well in some patients but don’t work at all in others,” said lead author Jeffrey Hubbell, Ph.D., a professor of tissue engineering … |
MIT Technology Review |
Gene–Therapy Grafts Have Repaired a Child’s Devastating Skin Disorder
MIT Technology Review Small patches of skin had been repaired this way before, but Jean Tang, a physician and associate professor of dermatology at Stanford, says this is the largest amount of skin that has been reconstructed by gene therapy to date. Tang and her colleagues … |